Product image of Isovurex (Ezetimibe) supplied by GNH India

Isovurex

Active Ingredient:
Ezetimibe
Origin:
EU

Isovurex (Ezetimibe)

Ezetimibe, the active ingredient in Isovurex, is a cholesterol absorption inhibitor presented as an oral tablet for oral use. It lowers low‑density lipoprotein cholesterol and is indicated for patients with hypercholesterolemia or mixed dyslipidemia, either alone or in combination with statins.

GNH India supplies Isovurex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Msn Labs Europe Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Isovurex is a cholesterol absorption inhibitor used to manage disorders of lipid metabolism.

  • Hypercholesterolemia: reduces LDL‑C levels as monotherapy or together with a statin.
  • Mixed dyslipidemia: lowers total cholesterol, LDL‑C and triglycerides while modestly increasing HDL‑C.
  • Statin‑intolerant patients with primary hypercholesterolemia: provides an alternative pathway for LDL‑C reduction.

How It Works

  • Ezetimibe selectively blocks the Niemann‑Pick C1‑like 1 (NPC1L1) transporter located on the brush border of enterocytes, preventing the intestinal uptake of dietary and biliary cholesterol. By reducing the amount of cholesterol delivered to the liver, hepatic cholesterol synthesis is down‑regulated and plasma LDL‑C concentrations fall.

Side Effects

Adverse reactions to ezetimibe are generally mild, but clinicians should be aware of both common and serious possibilities.

Common Side Effects

  • Abdominal pain: mild to moderate discomfort in the stomach area.
  • Diarrhea: loose stools occurring intermittently.
  • Fatigue: a feeling of tiredness not explained by other causes.
  • Headache: mild to moderate pain in the head.
  • Muscle pain: occasional soreness or aching.
  • Nausea: sensation of needing to vomit.

Serious or Rare Side Effects

  • Elevated liver enzymes: may indicate hepatic stress, especially when combined with statins.
  • Myopathy or rhabdomyysis: severe muscle breakdown, rare but serious.
  • Allergic reactions: rash, pruritus, or angioedema.
  • Pancreatitis: inflammation of the pancreas presenting with abdominal pain and vomiting.

Precautions & Warnings

Before initiating therapy, several safety considerations should be reviewed.

  • Baseline lipid assessment: document LDL‑C, HDL‑C and triglycerides.
  • Liver function monitoring: check ALT/AST periodically, especially with statin co‑therapy.
  • Gallbladder disease evaluation: ezetimibe may affect bile composition.
  • Concomitant statin use: assess risk of myopathy and adjust doses if needed.
  • Storage: Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Ezetimibe may interact with other medicines, requiring attention to the level of risk.

Major Interactions (Avoid)

  • Bile‑acid sequestrants (e.g., cholestyramine, colestipol): markedly reduce ezetimibe absorption.
  • High‑dose statins (e.g., rosuvastatin ≥40 mg): increase risk of myopathy.

Moderate Interactions (Monitor Closely)

  • Fibrates (gemfibrozil, fenofibrate): may raise liver enzyme levels.
  • Cyclosporine: can increase ezetimibe plasma concentrations.
  • Warfarin: monitor INR as ezetimibe may affect anticoagulation control.

Frequently Asked Questions

Isovurex contains ezetimibe, a cholesterol absorption inhibitor that is prescribed to lower elevated low‑density lipoprotein cholesterol and to improve overall lipid profiles in patients with hypercholesterolemia or mixed dyslipidemia, either as a stand‑alone therapy or together with a statin.

Ezetimibe blocks the NPC1L1 transporter on the intestinal brush border, preventing the uptake of dietary and biliary cholesterol. This reduces the amount of cholesterol delivered to the liver, leading to decreased hepatic cholesterol stores and a subsequent reduction in circulating LDL‑C levels.

The dosage of Isovurex is determined by the prescribing clinician based on the patient’s lipid profile, treatment goals, and any concomitant medications. The prescriber will select the appropriate strength and regimen according to current clinical guidelines.

Safety data for ezetimibe in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To place an order, submit an enquiry on the Isovurex product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Unlike statins, which inhibit HMG‑CoA reductase, ezetimibe reduces cholesterol absorption from the gut. It can be combined with statins for additive LDL‑C lowering, and it offers an alternative for patients who cannot tolerate high‑dose statins or need additional LDL‑C reduction.

Isovurex tablets should be stored at room temperature, below 25 °C, in the original packaging to protect them from moisture and light. Keep the product out of reach of children and do not use after the expiry date.

Isovurex is taken orally, usually once daily, with or without food, as directed by the prescriber. The tablet should be swallowed whole with a glass of water and not crushed or chewed.

Serious adverse events, though rare, include significant elevations in liver enzymes, especially when used with statins, and muscle toxicity such as myopathy or rhabdomyolysis. Patients should report unexplained muscle pain, weakness, or signs of liver dysfunction promptly.

Isovurex is contraindicated in individuals with known hypersensitivity to ezetimibe or any of its excipients. Caution is advised for patients with active liver disease, gallbladder disease, or those taking medications that may interact significantly, such as strong bile‑acid sequestrants.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ezetimibe

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT